FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joel Raskin

Research Profile

Chemicals & Drugs

Disorders

Procedures

Double-Blind Method

Concepts & Ideas

Devices

Placebos

Co-author Network

Publications

TOP 3
Min-Soo Lee; Joel Raskin; Richard Walton; Yong Min Ahn; Seockhoon Chung; Mun Sung Kim
The effect of initial duloxetine dosing strategy on nausea in korean patients with major depressive disorder.
Joel Raskin; George Weizhong Zhao; Thomas George; Renee E Granger; Nadia Hussain; Lauren B Marangell
Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.
D Sagman; D McIntosh; M S Lee; H Li; S Ruschel; N Hussain; R E Granger; A C Lee; Joel Raskin
Attributes of response in depressed patients switched to treatment with duloxetine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joel Raskin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Min-Soo Lee; Joel Raskin; Richard Walton; Yong Min Ahn; Seockhoon Chung; Mun Sung Kim
The effect of initial duloxetine dosing strategy on nausea in korean patients with major depressive disorder.
Psychiatry investigation 2012;9(4):391-9.
2012: Joel Raskin; George Weizhong Zhao; Thomas George; Renee E Granger; Nadia Hussain; Lauren B Marangell
Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.
Journal of psychiatric research 2012;46(5):667-74.
2011: D Sagman; D McIntosh; M S Lee; H Li; S Ruschel; N Hussain; R E Granger; A C Lee; Joel Raskin
Attributes of response in depressed patients switched to treatment with duloxetine.
International journal of clinical practice 2011;65(1):73-81.
2009: Min Soo Lee; Sun Young Yum; Jin Pyo Hong; Se Chang Yoon; Jai Sung Noh; Kwang Hun Lee; Jung Ki Kim; Sang Yeol Lee; Pritibha Singh; Tamas Treuer; Victoria Reed; Joel Raskin
Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder: A Three-Month Observational Study.
Psychiatry investigation 2009;6(4):255-63.
2009: Madelaine M Wohlreich; Mark D Sullivan; Craig H Mallinckrodt; Amy S Chappell; Tina M Oakes; John G Watkin; Joel Raskin
Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritis.
Psychosomatics 2009;50(4):402-12.
2009: Q Q Ang; Y K Wing; Y He; A H Sulaiman; N-Y Chiu; Y-C Shen; G Wang; C Zhang; K-H Lee; Pritibha Singh; R E Granger; Joel Raskin; M Dossenbach
Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study.
International journal of clinical practice 2009;63(7):1041-9.
2009: Ajay D Wasan; Melissa J Ossanna; Joel Raskin; Joachim F Wernicke; Michael J Robinson; Jerry A Hall; Sara E Edwards; Sarah Lipsius; Adam L Meyers; Bill H McCarberg
Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.
Current drug safety 2009;4(1):22-9.
2008: Mark H Pollack; Susan G Kornstein; Melissa E Spann; Paul Crits-Christoph; Joel Raskin; James M Russell
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint.
Journal of psychiatric research 2008;42(14):1176-84.
2008: Jonathan Davidson; Christer Allgulander; Mark Pollack; James Hartford; Janelle S Erickson; James M Russell; David Perahia; Madelaine M Wohlreich; Janice Carlson; Joel Raskin
Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies.
Human psychopharmacology 2008;23(6):519-26.
2008: Joel Raskin; Jimmy Y Xu; Daniel K Kajdasz
Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorder.
International psychogeriatrics / IPA 2008;20(2):309-27.
2008: Joel Raskin; Curtis G Wiltse; James J Dinkel; Daniel J Walker; Durisala Desaiah; Cornelius Katona
Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder.
Journal of clinical psychopharmacology 2008;28(1):32-8.
2008: David Perahia; Yili Lu Pritchett; Daniel K Kajdasz; Michael Bauer; Rakesh Jain; James M Russell; Daniel J Walker; Kimberly A Spencer; Debbie M Froud; Joel Raskin; Michael E Thase
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Journal of psychiatric research 2008;42(1):22-34.
2008: Moira Rynn; James Russell; Janelle Erickson; Michael Detke; Susan Ball; Jeff Dinkel; Karl Rickels; Joel Raskin
Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
Depression and anxiety 2008;25(3):182-9.
2007: Stephan Brecht; Christine Courtecuisse; Catherine Debieuvre; Jens Croenlein; Durisala Desaiah; Joel Raskin; Claude Petit; Koen Demyttenaere
Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
The Journal of clinical psychiatry 2007;68(11):1707-16.
2007: Richard C Shelton; Anne C Andorn; Craig H Mallinckrodt; Madelaine M Wohlreich; Joel Raskin; John G Watkin; Michael Detke
Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression.
International clinical psychopharmacology 2007;22(6):348-55.
2007: Joachim F Wernicke; Fujun Wang; Yili Lu Pritchett; Timothy R Smith; Joel Raskin; Deborah N D'Souza; Smriti Iyengar; Amy S Chappell
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Pain medicine (Malden, Mass.) 2007;8(6):503-13.
2007: Richard C Shelton; A Prakash; Craig H Mallinckrodt; Madelaine M Wohlreich; Joel Raskin; M J Robinson; Michael Detke
Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
International journal of clinical practice 2007;61(8):1337-48.
2007: Thomas N Wise; Curtis G Wiltse; D V Iosifescu; M Sheridan; J Y Xu; Joel Raskin
The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.
International journal of clinical practice 2007;61(8):1283-93.
2007: Christer Allgulander; James Hartford; James Russell; Susan Ball; Janelle Erickson; Joel Raskin; Moira Rynn
Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
Current medical research and opinion 2007;23(6):1245-52.
2007: Joel Raskin; Curtis G Wiltse; Alan Siegal; Javaid Sheikh; Jimmy Xu; James J Dinkel; Benjamin T Rotz; Richard C Mohs
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
The American journal of psychiatry 2007;164(6):900-9.
2007: Phil Lee; Liang Shu; Xiufeng Xu; Chuan Yue Wang; Min Soo Lee; Chia-Yih Liu; Jin Pyo Hong; Sandra Ruschel; Joel Raskin; Samuel A Colman; Gavan A Harrison
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Psychiatry and clinical neurosciences 2007;61(3):295-307.
2007: Jean Endicott; James M Russell; Joel Raskin; Michael Detke; Janelle Erickson; Susan G Ball; Martin D Marciniak; Ralph W Swindle
Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies.
The Journal of clinical psychiatry 2007;68(4):518-24.
2007: Joachim F Wernicke; Alberto Lledó; Joel Raskin; Daniel K Kajdasz; Fujun Wang
An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(5):437-55.
2006: David Perahia; Yili Lu Pritchett; Durisala Desaiah; Joel Raskin
Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
International clinical psychopharmacology 2006;21(6):311-7.
2006: Joachim F Wernicke; Yili Lu Pritchett; Deborah N D'Souza; A Waninger; P Tran; Smriti Iyengar; Joel Raskin
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Neurology 2006;67(8):1411-20.
2006: Joel Raskin; Fujun Wang; Yili Lu Pritchett; David J Goldstein
Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.
Pain medicine (Malden, Mass.) 2006;7(5):373-85.
2006: David Perahia; Daniel K Kajdasz; Mary G Royer; Daniel J Walker; Joel Raskin
Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics.
International clinical psychopharmacology 2006;21(5):285-95.
2006: Maurizio Fava; Michael Detke; Matteo Balestrieri; Fujun Wang; Joel Raskin; David Perahia
Management of depression relapse: re-initiation of duloxetine treatment or dose increase.
Journal of psychiatric research 2006;40(4):328-36.
2006: David Perahia; Daniel K Kajdasz; Daniel J Walker; Joel Raskin; A Tylee
Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
International journal of clinical practice 2006;60(5):613-20.
2006: Joel Raskin; Timothy R Smith; Kar Wong; Yili Lu Pritchett; Deborah N D'Souza; Smriti Iyengar; Joachim F Wernicke
Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
Journal of palliative medicine 2006;9(1):29-40.
2005: Joel Raskin; Yili Lu Pritchett; Fujun Wang; Deborah N D'Souza; Amy L Waninger; Smriti Iyengar; Joachim F Wernicke
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.
Pain medicine (Malden, Mass.) 2005;6(5):346-56.
2005: Craig H Mallinckrodt; John G Watkin; Chaofeng Liu; Madelaine M Wohlreich; Joel Raskin
Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
BMC psychiatry 2005;5():1.
2004: John H Greist; Robert K McNamara; Craig H Mallinckrodt; Jyoti N Rayamajhi; Joel Raskin
Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
Clinical therapeutics 2004;26(9):1446-55.
2004: Craig H Mallinckrodt; Joel Raskin; Madelaine M Wohlreich; John G Watkin; Michael Detke
The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.
BMC psychiatry 2004;4():26.
2003: Joel Raskin; David J Goldstein; Craig H Mallinckrodt; Margaret B Ferguson
Duloxetine in the long-term treatment of major depressive disorder.
The Journal of clinical psychiatry 2003;64(10):1237-44.
2002: Sidney H Kennedy; Sonia M McCann; Mario Masellis; Roger S McIntyre; Joel Raskin; Gordon McKay; Glen B Baker
Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
The Journal of clinical psychiatry 2002;63(3):181-6.
2001: Jamie Karagianis; I C Dawe; A Thakur; S Bégin; Joel Raskin; S M Roychowdhury
Rapid tranquilization with olanzapine in acute psychosis: a case series.
The Journal of clinical psychiatry 2001;62 Suppl 2():12-6.
1987: Donna E Stewart; Joel Raskin; Paul E Garfinkel; O L MacDonald; G E Robinson
Anorexia nervosa, bulimia, and pregnancy.
American journal of obstetrics and gynecology 1987;157(5):1194-8.
1986: D E Stewart; Joel Raskin
Hypersensitivity disorder and vernacular science.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1986;134(12):1344-6.
1985: D E Stewart; Joel Raskin
Psychiatric assessment of patients with "20th-century disease" ("total allergy syndrome").
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1985;133(10):1001-6.